High-risk percutaneous coronary intervention with Impella CP hemodynamic support. A case series and method presentation
نویسندگان
چکیده
Corresponding author: Adam Sukiennik MD, PhD, Department of Cardiology and Internal Diseases, University Hospital No. 1, Collegium Medicum, Nicolaus Copernicus University, 9 M. Skłodowskiej-Curie St, 85-094 Bydgoszcz, Poland, phone: +48 52 585 40 23, fax: +48 52 585 40 24, e-mail: [email protected] Received: 10.02.2016, accepted: 6.09.2016. High-risk percutaneous coronary intervention with Impella CP hemodynamic support. A case series and method presentation
منابع مشابه
Avoiding hemodynamic collapse during high-risk percutaneous coronary intervention: Advanced hemodynamics of impella support.
The rate of performing primary percutaneous coronary intervention in patients with complex coronary artery disease is increasing. The use of percutaneous mechanical circulatory support devices provides critical periprocedural hemodynamic support. Mechanical support has increased the safety and efficacy of interventional procedures in this high-risk patient population. Predicting patient respons...
متن کاملA prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study.
BACKGROUND Although coronary artery bypass grafting is generally preferred in symptomatic patients with severe, complex multivessel, or left main disease, some patients present with clinical features that make coronary artery bypass grafting clinically unattractive. Percutaneous coronary intervention with hemodynamic support may be feasible for these patients. Currently, there is no systematic ...
متن کاملCirculatory support with Impella CP device during high-risk percutaneous coronary interventions: initial experience in Poland
Corresponding author: Dariusz Dudek MD, PhD, Department of Interventional Cardiology, Jagiellonian University Medical College, Institute of Cardiology, 17 Kopernika St, 31-501 Krakow, Poland, phone: +48 12 424 71 81, fax: +48 12 424 71 84, e-mail: [email protected] Received: 1.03.2016, accepted: 14.06.2016. Circulatory support with Impella CP device during high-risk percutaneous coronary inte...
متن کاملA prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience.
OBJECTIVES We sought to evaluate the safety and feasibility of the Impella 2.5 system (Abiomed Inc., Danvers, Massachusetts) in patients undergoing high-risk percutaneous coronary intervention (PCI). BACKGROUND The Impella 2.5 is a miniaturized percutaneous cardiac assist device, which provides up to 2.5 l/min forward flow from the left ventricle into the systemic circulation. METHODS In a ...
متن کاملSupported high-risk percutaneous coronary intervention with the Impella 2.5 device the Europella registry.
OBJECTIVES This retrospective multicenter registry evaluated the safety and feasibility of left ventricular (LV) support with the Impella 2.5 (Abiomed Europe GmbH, Aachen, Germany) during high-risk percutaneous coronary intervention (PCI). BACKGROUND Patients with complex or high-risk coronary lesions, such as last remaining vessel or left main lesions, are increasingly being treated with PCI...
متن کامل